163 related articles for article (PubMed ID: 18587549)
21. Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study.
Daniltchenko DI; Riedl CR; Sachs MD; Koenig F; Daha KL; Pflueger H; Loening SA; Schnorr D
J Urol; 2005 Dec; 174(6):2129-33, discussion 2133. PubMed ID: 16280742
[TBL] [Abstract][Full Text] [Related]
22. Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies.
Kausch I; Sommerauer M; Montorsi F; Stenzl A; Jacqmin D; Jichlinski P; Jocham D; Ziegler A; Vonthein R
Eur Urol; 2010 Apr; 57(4):595-606. PubMed ID: 20004052
[TBL] [Abstract][Full Text] [Related]
23. Real-world experience with 5-aminolevulinic acid for the photodynamic diagnosis of bladder cancer: Diagnostic accuracy and safety.
Yamamoto S; Fukuhara H; Karashima T; Inoue K
Photodiagnosis Photodyn Ther; 2020 Dec; 32():101999. PubMed ID: 32920180
[TBL] [Abstract][Full Text] [Related]
24. Feasibility of photodynamic diagnosis for challenging TUR- Bt cases including muscle invasive bladder cancer, BCG failure or 2nd-TUR.
Takai T; Inamoto T; Komura K; Yoshikawa Y; Uchimoto T; Saito K; Tanda N; Kouno J; Minami K; Uehara H; Takahara K; Hirano H; Nomi H; Kiyama S; Azuma H
Asian Pac J Cancer Prev; 2015; 16(6):2297-301. PubMed ID: 25824753
[TBL] [Abstract][Full Text] [Related]
25. 5-aminolevulinic acid-mediated photodynamic diagnosis using fluorescence ureterorenoscopy for urinary upper tract urothelial carcinoma ∼Preliminary prospective single centre trial∼.
Fukuhara H; Kurabayashi A; Furihata M; Setuda S; Takahashi K; Murakami K; Tanaka T; Inoue K
Photodiagnosis Photodyn Ther; 2020 Mar; 29():101617. PubMed ID: 31857216
[TBL] [Abstract][Full Text] [Related]
26. Role of hexaminolevulinate-guided fluorescence cystoscopy in bladder cancer: critical analysis of the latest data and European guidance.
Malmström PU; Grabe M; Haug ES; Hellström P; Hermann GG; Mogensen K; Raitanen M; Wahlqvist R
Scand J Urol Nephrol; 2012 Apr; 46(2):108-16. PubMed ID: 22087730
[TBL] [Abstract][Full Text] [Related]
27. Oral 5-aminolevulinic acid mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A randomized, double-blind, multicentre phase II/III study.
Inoue K; Anai S; Fujimoto K; Hirao Y; Furuse H; Kai F; Ozono S; Hara T; Matsuyama H; Oyama M; Ueno M; Fukuhara H; Narukawa M; Shuin T
Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):193-200. PubMed ID: 25843912
[TBL] [Abstract][Full Text] [Related]
28. The sustaining of fluorescence in photodynamic diagnosis after the administration of 5-aminolevulinic acid in carcinogen-induced bladder cancer orthotopic rat model and urothelial cancer cell lines.
Owari T; Iwamoto T; Anai S; Miyake M; Nakai Y; Hori S; Hara T; Ishii T; Ota U; Torimoto K; Kuniyasu H; Fujii T; Tanaka N; Fujimoto K
Photodiagnosis Photodyn Ther; 2021 Jun; 34():102309. PubMed ID: 33901687
[TBL] [Abstract][Full Text] [Related]
29. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.
Babjuk M; Burger M; Zigeuner R; Shariat SF; van Rhijn BW; Compérat E; Sylvester RJ; Kaasinen E; Böhle A; Palou Redorta J; Rouprêt M;
Eur Urol; 2013 Oct; 64(4):639-53. PubMed ID: 23827737
[TBL] [Abstract][Full Text] [Related]
30. Oral 5-aminolevulinic acid-mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A multicenter phase III study.
Nakai Y; Inoue K; Tsuzuki T; Shimamoto T; Shuin T; Nagao K; Matsuyama H; Oyama M; Furuse H; Ozono S; Miyake M; Fujimoto K
Int J Urol; 2018 Aug; 25(8):723-729. PubMed ID: 29999205
[TBL] [Abstract][Full Text] [Related]
31. Photodynamic Diagnosis-Assisted En Bloc Transurethral Resection of Bladder Tumor for Nonmuscle Invasive Bladder Cancer: Short-Term Oncologic and Functional Outcomes.
Miyake M; Nishimura N; Fujii T; Miyamoto T; Iida K; Hori S; Morizawa Y; Gotoh D; Nakai Y; Anai S; Torimoto K; Tanaka N; Fujimoto K
J Endourol; 2021 Mar; 35(3):319-327. PubMed ID: 32940054
[No Abstract] [Full Text] [Related]
32. [Follow-up of urological tumor treatment].
Ohlmann CH; Albers P; Boehm K; Graefen M; Hakenberg OW; Kuczyk M; Graf J; Peters I; Protzel C
Urologe A; 2015 Sep; 54(9):1223-33. PubMed ID: 26246111
[TBL] [Abstract][Full Text] [Related]
33. Is photodynamic diagnosis ready for introduction in urological clinical practice?
Cordeiro ER; Anastasiadis A; Bus MT; Alivizatos G; de la Rosette JJ; de Reijke TM
Expert Rev Anticancer Ther; 2013 Jun; 13(6):669-80. PubMed ID: 23773102
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic performance of image technique based transurethral resection for non-muscle invasive bladder cancer: systematic review and diagnostic meta-analysis.
Chen C; Huang H; Zhao Y; Liu H; Sylvester R; Lin T; Huang J
BMJ Open; 2019 Oct; 9(10):e028173. PubMed ID: 31628123
[TBL] [Abstract][Full Text] [Related]
35. [Fluorescence diagnosis in patients with non-muscle invasive bladder cancer: results of a metaanalysis].
Kausch I; Sommerauer M; Montorsi F; Stenzl A; Jacqmin D; Jichlinski P; Jocham D; Ziegler A; Vonthein R
Aktuelle Urol; 2010 May; 41(3):171-7. PubMed ID: 20486035
[TBL] [Abstract][Full Text] [Related]
36. DaBlaCa-11: Photodynamic Diagnosis in Flexible Cystoscopy-A Randomized Study With Focus on Recurrence.
Drejer D; Moltke AL; Nielsen AM; Lam GW; Jensen JB
Urology; 2020 Mar; 137():91-96. PubMed ID: 31843623
[TBL] [Abstract][Full Text] [Related]
37. [Clinical experience with intravesical instillations of 5-aminolevulinic acid (5-ALA) for the photodynamic diagnosis using fluorescence cystoscopy for bladder cancer].
Inoue K; Karashima T; Kamada M; Kurabayashi A; Ohtsuki Y; Shuin T
Nihon Hinyokika Gakkai Zasshi; 2006 Jul; 97(5):719-29. PubMed ID: 16898595
[TBL] [Abstract][Full Text] [Related]
38. 5-Aminolevulinic acid-induced fluorescence endoscopy for the detection of lower urinary tract tumors.
Kriegmair M; Zaak D; Knuechel R; Baumgartner R; Hofstetter A
Urol Int; 1999; 63(1):27-31. PubMed ID: 10592487
[TBL] [Abstract][Full Text] [Related]
39. [Fluorescence cystoscopy at bladder cancer: present trials].
Zaak D; Karl A; Stepp H; Tritschler S; Tilki D; Burger M; Knuechel R; Stief C
Urologe A; 2007 Nov; 46(11):1519-27. PubMed ID: 17928985
[TBL] [Abstract][Full Text] [Related]
40. [Hexaminolevulinate photodynamic diagnosis in non-muscle invasive bladder cancer: experience of the BLUE group].
Burgués JP; Conde G; Oliva J; Abascal JM; Iborra I; Puertas M; Ordoño F;
Actas Urol Esp; 2011 Sep; 35(8):439-45. PubMed ID: 21621301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
